09/13/2012
Jessica L. Wallace, PharmD; Judith E. Soberman, MD, FACC; Jimmie Mancell, MD; Maegan L. Rogers, PharmD, BCPS; Timothy H. Self, PharmD
<p>The benefits of&nbsp;<em>cardioselective&nbsp;</em>beta-blocker therapy outweigh the associated risks in patients with nonsevere asthma after myocardial infarction (MI) or for...
